Oral absorption and concentration‐effect relationship of tyramine with and without cimoxatone, a type‐A specific inhibitor of monoamine oxidase

[1]  C. Fowler,et al.  The Metabolism of Dopamine by Both Forms of Monoamine Oxidase in the Rat Brain and Its Inhibition by Cimoxatone , 1983, Journal of neurochemistry.

[2]  C. Fowler,et al.  Cimoxatone Is a Reversible Tight‐Binding Inhibitor of the A Form of Rat Brain Monoamine Oxidase , 1983, Journal of neurochemistry.

[3]  E. Malveaux,et al.  Studies on the effect of antidepressants on kinetics and metabolism of tyramine. , 1981, The Journal of pharmacology and experimental therapeutics.

[4]  J. Kan,et al.  Characteristics of the Inhibition of Rat Brain Monoamine Oxidase In Vitro by MD780515 , 1981, Journal of neurochemistry.

[5]  D. Davies,et al.  The effect of monoamine oxidase inhibitors on 'first-pass' metabolism of tyramine in dog intestine. , 1980, Biochemical pharmacology.

[6]  P. Sever,et al.  PRESSOR AMINES AND MONOAMINE-OXIDASE INHIBITORS FOR TREATMENT OF POSTURAL HYPOTENSION IN AUTONOMIC FAILURE Limitations and Hazards , 1978, The Lancet.

[7]  M. Houslay,et al.  Multiple forms of monoamine oxidase: Fact and artefact , 1976 .

[8]  C. Goridis,et al.  Monoamine oxidase in sympathetic nerves: a transmitter specific enzyme type , 1971, British journal of pharmacology.

[9]  B. Jarrott.  OCCURRENCE AND PROPERTIES OF MONOAMINE OXIDASE IN ADRENERGIC NEURONS , 1971, Journal of neurochemistry.

[10]  M. Tansella,et al.  Interactions between sympathomimetic amines and a new monoamine oxidase inhibitor , 1970, Psychopharmacologia.

[11]  L. I. Goldberg,et al.  MONOAMINE OXIDASE INHIBITORS. ADVERSE REACTIONS AND POSSIBLE MECHANISMS. , 1964, JAMA.

[12]  B. Blackwell.  HYPERTENSIVE CRISIS DUE TO MONOAMINE-OXIDASE INHIBITORS. , 1963, Lancet.

[13]  C. Dollery,et al.  HÆMODYNAMIC STUDIES WITH METHYLDOPA: EFFECT ON CARDIAC OUTPUT AND RESPONSE TO PRESSOR AMINES , 1963, British heart journal.

[14]  M. Rand,et al.  TACHYPHYLAXIS TO SOME SYMPATHOMIMETIC AMINES IN RELATION TO MONOAMINE OXIDASE. , 1963, British journal of pharmacology and chemotherapy.

[15]  J. Axelrod,et al.  Effect of Drugs on the Uptake and Release of 3H-Norepinephrine in the Rat Heart , 1962, Nature.

[16]  H. Schümann,et al.  Release of Catechol Amines from Isolated Medullary Granules by Sympathomimetic Amines , 1962, Nature.

[17]  M. Rand,et al.  The action of sympathomimetic amines in animals treated with reserpine , 1958, The Journal of physiology.

[18]  G. Alles.  THE COMPARATIVE PHYSIOLOGICAL ACTIONS OF dl-β-PHENYLISOPROPYLAMINES I. PRESSOR EFFECT AND TOXICITY , 1933 .

[19]  D. Murphy,et al.  Tyramine infusions and selective monoamine oxidase inhibitor treatment , 2004, Psychopharmacology.

[20]  G. Stern,et al.  Is the failure of (-)deprenyl, a selective monoamine oxidase B inhibitor, to alleviate depression related to freedom from the cheese effect? , 2004, Psychopharmacology.

[21]  A. Carlsson,et al.  Intestinal metabolism of tyramine by both forms of monoamine oxidase in the rat. , 1983, Biochemical pharmacology.

[22]  B. Blackwell,et al.  Interactions of monoamine oxidase inhibitors, amines, and foodstuffs. , 1970, Advances in pharmacology and chemotherapy.